Nipro Corporation

Nipro Corporation

NPRRF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$224.18B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Nipro CorporationNipro Corporation20.82.26%3%-2.1

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$224.18 Billion
Enterprise Value$759.11 Billion
Annual dividend$0.20
Dividend yield2.26%
Earnings per Share$-
Beta-0.61
Outstanding Shares-

Return

Return on Equity3.45%ROE
Return on Assets0.86%
Return on Invested Capital4.57%

Valuation & Multiples

P/E Ratio20.77P/E Ratio
PEG-16.91PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue1.11
Enterprise Value to EBIT20.6
Enterprise Value to Net Income70
Total Debt to Enterprise0.87
Debt to Equity2.11Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 10, 2026
EPS
-$0.02
Est. $0.14
Revenue
$1.09 B
Est. $1.05 B

Next Earnings Call

Expected Date
February 10, 2027
EPS Estimate
$0.34
Consensus analyst estimate
Revenue Estimate
$1.12 B
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Nipro Corporation

38,593 employees
CEO: Yoshihiko Sano

Nipro Corporation, along with its affiliated companies, operates across three primary business divisions: medical devices, pharmaceuticals, and pharmaceutical packaging. The company's Medical Device sector is dedicated to the development...